RecallDepth
Class II Terminated

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

Company
Actavis Inc
Recall Initiated
January 30, 2017
Posted
February 22, 2017
Recall Number
D-0476-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
499320 units
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

Distribution

Nationwide in US

Lot / Code Info

Lot #: 3134201, 3134202, Exp. 06/30/17; 3134319, Exp. 05/31/17; 3135246, Exp. 07/31/17; 3135247, 3136781, Exp. 08/31/17; 3136782, Exp. 09/30/17; 3136903, 3136904, Exp.10/31/17; 3138250, Exp. 07/31/17; 3138968, Exp. 08/31/17; 3140000, Exp. 09/30/17

More recalls by Actavis Inc

View all recalls by this company →

Other recent Class II Drug recalls